Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital.
- Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital.
- Portal is committed to ensuring broad accessibility of its platform to enable a variety of research and therapeutic applications.
- The company was founded by Armon Sharei, Ph.D., founder and former CEO of SQZ Biotechnologies.
- “We are very excited to join the Portal team and support their mission to solve one of the field's major long-standing challenges,” said Eddie Eltoukhy, Partner and lead investor from Pear VC.